ID

33185

Description

Study ID: 104021 Clinical Study ID: 104021 Study Title: A phase III, partially blind, randomized study to evaluate the immunogenicity, safety and reactogenicity of GlaxoSmithKline (GSK) Biologicals’ Tritanrix™-HepB and GSK Biologicals Kft’s DTPw-HBV vaccines as compared to concomitant administration of Commonwealth Serum Laboratory’s (CSL’s) DTPw (Triple Antigen™) and GSK Biologicals’ HBV (Engerix™-B), when co-administered with GSK Biologicals’ oral live attenuated human rotavirus (HRV) vaccine, to healthy infants at 3, 4½ and 6 months of age, after a birth dose of hepatitis B vaccine. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00158756 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix B Study Indication: Hepatitis B

Mots-clés

  1. 30/11/2018 30/11/2018 -
  2. 30/11/2018 30/11/2018 -
Détendeur de droits

GSK group of companies

Téléchargé le

30 novembre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Immunogenicity of co-administration of Tritanrix™-HepB and DTPw-HBV vaccines or Triple Antigen™ and Engerix™-B with HRV vaccine to infants (3, 4½ and 6 month) - 104021

Visit 4: Study Continuation Check

Administrative data
Description

Administrative data

Subject Number
Description

Subject Number

Type de données

integer

Check for Study Continuation
Description

Check for Study Continuation

Did the subject return for visit 4?
Description

Did the subject return for visit 4?

Type de données

boolean

If yes, please complete all forms for Visit 4
Description

If yes, please complete all forms for Visit 4

Type de données

text

If No, record ONE most appropriate reason and skip the following pages of this visit
Description

If No, record ONE most appropriate reason and skip the following pages of this visit

Type de données

text

If SAE, record the SAE number
Description

If SAE, record the SAE number

Type de données

integer

If Non-SAE, record the unsolicited AE number
Description

If Non-SAE, record the unsolicited AE number

Type de données

integer

If Other, specify
Description

e.g., consent withdrawal, protocol violation, etc.

Type de données

text

Who took the decision?
Description

Who took the decision?

Type de données

text

Similar models

Visit 4: Study Continuation Check

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
Subject Number
Item
Subject Number
integer
Item Group
Check for Study Continuation
Did the subject return for visit 4?
Item
Did the subject return for visit 4?
boolean
If yes, please complete all forms for Visit 4
Item
If yes, please complete all forms for Visit 4
text
Item
If No, record ONE most appropriate reason and skip the following pages of this visit
text
Code List
If No, record ONE most appropriate reason and skip the following pages of this visit
CL Item
Serious Adverse Event (1)
CL Item
Non-Serious adverse event (2)
CL Item
Other (3)
If SAE, record the SAE number
Item
If SAE, record the SAE number
integer
If Non-SAE, record the unsolicited AE number
Item
If Non-SAE, record the unsolicited AE number
integer
If Other, specify
Item
If Other, specify
text
Item
Who took the decision?
text
Code List
Who took the decision?
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial